News | April 08, 2011

SPECT Upgrade Significantly Cuts Exam Time

April 8, 2011 – At the American College of Cardiology (ACC) Annual Scientific Meeting in New Orleans, Siemens Healthcare demonstrated how users of nuclear imaging systems can use its IQ•SPECT to help reduce the length of imaging protocols.

A field-upgradeable combination of hardware and software, IQ•SPECT is available on the company’s Symbia S and Symbia T series single photon emission computed tomography (SPECT) and SPECT-CT systems. The company says it is helping nuclear cardiologists cut the cardiac imaging protocol from 20 minutes to less than five minutes. These shortened exams can potentially reduce radiation dose and provide high quality diagnostic information.

“There is a significant difference between a four-minute SPECT scan with IQ•SPECT and a conventional 20-minute SPECT because many older patients cannot tolerate a longer scan,” said James R. Corbett, M.D., director, cardiovascular nuclear medicine, professor, departments of internal medicine and radiology, University Hospital, University of Michigan Health System. “In our practice IQ•SPECT provides the opportunity to obtain quality SPECT imaging information in cases where it would not have been possible to even attempt imaging.”

Siemens recently received the Product Differentiation Excellence Award, Nuclear Cardiology, North America, 2011, from Frost and Sullivan.

“Despite the benefits to clinical decision making conferred by the modality, the cardiac SPECT market has been faced with challenging circumstances that have led to a significant shift in the traditional provider setting,” said Sangeetha Prabakar, industry analyst, Frost and Sullivan. “With IQ•SPECT, Siemens has delivered a solution that addresses the cost sensibilities engendered by decreased reimbursement and the relative scarcity of the radiotracer. Using a field-upgradeable approach to providing high-quality imaging in almost a quarter of the time of conventional SPECT, Siemens has clearly demonstrated its leadership in this space.”

Siemens said the technology has been shown to reduce radiotracer doses by up to 50 percent, translating into lower amounts of radiation for the patient and potential cost savings. IQ•SPECT utilizes Smartzoom collimators, which focus on the heart, collecting up to four times more counts than conventional, large-bore, parallel-hole collimators. It also uses cardio-centric orbit acquisition, which ensures that the heart is always in the collimator’s magnification zone, as opposed to the gantry’s mechanical center. A 3-D reconstruction algorithm models the position of each of the 48,000 collimator holes on each detector, allowing distant-dependent isotropic (3-D) resolution recovery, CT-based attenuation correction and energy window-based scatter correction.

For more information: www.siemens.com/healthcare

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Overlay Init